Financing Arrangements (Tables)

12 Months Ended

Jun. 30, 2013

Long-term Debt and Capital Lease Obligations [Abstract]

Schedule of Long-term Debt

A summary of the Company’s long-term debt as of June 30, 2012 and 2013 follows (in millions).

	June 30, 2012			June 30, 2013
8.0% Senior Unsecured Notes due 2018	$	1,159.1		$	1,161.9
7.750% Senior Notes due 2019	722.2			722.7
10.375% Senior Discount Notes due 2016	9.9			—
Term loans payable under credit facility due 2016	798.8			1,092.9
Capital leases and other long term debt	16.6			18.7
	2,706.6			2,996.2
Less: current maturities	(11.2		)	(16.9		)
	$	2,695.4		$	2,979.3

Schedule of Condensed Balance Sheets

VANGUARD HEALTH SYSTEMS, INC.

Condensed Consolidating Balance Sheets

June 30, 2012

	Parent		Issuers of Senior Notes and Term Debt			Issuers of Senior Discount Notes			Guarantor Subsidiaries		Combined Non- Guarantors		Eliminations			Total Consolidated
	(In millions)
ASSETS
Current assets:
Cash and cash equivalents	$	—	$	—		$	—		$	305.8	$	149.7	$	—		$	455.5
Restricted cash	—		—			—			0.8		1.6		—			2.4
Accounts receivable, net	—		—			—			588.1		114.0		—			702.1
Inventories	—		—			—			86.1		10.9		—			97.0
Prepaid expenses and other current assets	0.1		—			—			271.7		54.2		—			326.0
Total current assets	0.1		—			—			1,252.5		330.4		—			1,583.0
Property, plant and equipment, net	—		—			—			1,802.6		307.5		—			2,110.1
Goodwill	—		—			—			668.1		100.3		—			768.4
Intangible assets, net	—		49.0			0.3			27.0		12.7		—			89.0
Investments in consolidated subsidiaries	608.8		—			—			—		—		(608.8		)	—
Investments in securities	—		—			—			—		51.8		—			51.8
Intercompany receivable	—		1,674.2			—			—		—		(1,674.2		)	—
Other assets	—		—			—			83.3		102.5		—			185.8
Total assets	$	608.9	$	1,723.2		$	0.3		$	3,833.5	$	905.2	$	(2,283.0	)	$	4,788.1
LIABILITIES AND EQUITY
Current liabilities:
Accounts payable	$	—	$	—		$	—		$	309.8	$	73.8	$	—		$	383.6
Accrued expenses and other current liabilities	0.1		73.2			—			399.9		120.7		—			593.9
Current maturities of long-term debt	—		8.2			—			1.9		1.1		—			11.2
Total current liabilities	0.1		81.4			—			711.6		195.6		—			988.7
Other liabilities	—		—			—			547.6		201.8		—			749.4
Long-term debt, less current maturities	—		2,672.0			9.9			4.2		9.3		—			2,695.4
Intercompany payable	307.3		—			66.7			1,546.5		130.6		(2,051.1		)	—
Redeemable non-controlling interests	—		—			—			—		53.1		—			53.1
Total equity (deficit)	301.5		(1,030.2		)	(76.3		)	1,023.6		314.8		(231.9		)	301.5
Total liabilities and equity	$	608.9	$	1,723.2		$	0.3		$	3,833.5	$	905.2	$	(2,283.0	)	$	4,788.1

VANGUARD HEALTH SYSTEMS, INC.

Condensed Consolidating Balance Sheets

June 30, 2013

	Parent		Issuers of Senior Notes and Term Debt			Issuers of Senior Discount Notes			Guarantor Subsidiaries		Combined Non- Guarantors		Eliminations			Total Consolidated
	(In millions)
ASSETS
Current assets:
Cash and cash equivalents	$	—	$	—		$	—		$	512.3	$	111.7	$	—		$	624.0
Restricted cash	—		—			—			4.9		1.6		—			6.5
Accounts receivable, net	—		—			—			520.8		115.9		—			636.7
Inventories	—		—			—			90.7		11.0		—			101.7
Prepaid expenses and other current assets	—		—			—			212.5		60.4		—			272.9
Total current assets	—		—			—			1,341.2		300.6		—			1,641.8
Property, plant and equipment, net	—		—			—			2,024.7		300.3		—			2,325.0
Goodwill	—		—			—			689.6		100.3		—			789.9
Intangible assets, net	—		42.6			—			28.7		9.3		—			80.6
Investments in consolidated subsidiaries	608.8		—			—			—		—		(608.8		)	—
Investments in securities	—		—			—			—		59.1		—			59.1
Intercompany receivable	—		1,770.8			—			—		—		(1,770.8		)	—
Other assets	—		—			—			28.4		117.8		—			146.2
Total assets	$	608.8	$	1,813.4		$	—		$	4,112.6	$	887.4	$	(2,379.6	)	$	5,042.6
LIABILITIES AND EQUITY
Current liabilities:
Accounts payable	$	—	$	—		$	—		$	324.3	$	70.6	$	—		$	394.9
Accrued expenses and other current liabilities	—		73.6			—			407.4		104.8		—			585.8
Current maturities of long-term debt	—		10.9			—			3.5		2.5		—			16.9
Total current liabilities	—		84.5			—			735.2		177.9		—			997.6
Other liabilities	—		—			—			455.5		142.4		—			597.9
Long-term debt, less current maturities	—		2,966.6			—			3.4		9.3		—			2,979.3
Intercompany payable	202.8		—			78.0			1,676.0		190.9		(2,147.7		)	—
Redeemable non-controlling interests	—		—			—			—		61.8		—			61.8
Total equity (deficit)	406.0		(1,237.7		)	(78.0		)	1,242.5		305.1		(231.9		)	406.0
Total liabilities and equity	$	608.8	$	1,813.4		$	—		$	4,112.6	$	887.4	$	(2,379.6	)	$	5,042.6

Schedule of Condensed Income Statements

VANGUARD HEALTH SYSTEMS, INC.

Condensed Consolidating Statements of Operations

For the year ended June 30, 2011

	Parent			Issuers of Senior Notes and Term Debt			Issuers of Senior Discount Notes			Guarantor Subsidiaries			Combined Non- Guarantors			Eliminations			Total Consolidated
	(In millions)
Patient service revenues, net	$	—		$	—		$	—		$	3,558.3		$	183.8		$	(29.8	)	$	3,712.3
Premium revenues	—			—			—			58.5			815.0			(4.1		)	869.4
Total revenues	—			—			—			3,616.8			998.8			(33.9		)	4,581.7
Salaries and benefits	4.8			—			—			1,914.0			101.6			—			2,020.4
Health plan claims expense	—			—			—			33.7			682.4			(29.8		)	686.3
Supplies	—			—			—			636.8			33.1			—			669.9
Purchased services	—			—			—			333.1			27.8			—			360.9
Rents and leases	—			—			—			47.2			6.9			—			54.1
Other operating expenses	0.3			—			—			344.2			43.4			(4.1		)	383.8
Medicare and Medicaid EHR incentives	—			—			—			(10.1		)	—			—			(10.1		)
Depreciation and amortization	—			—			—			181.9			11.9			—			193.8
Interest, net	—			145.5			32.9			(11.3		)	4.1			—			171.2
Impairment and restructuring charges	—			—			—			6.0			—			—			6.0
Monitoring fees and expenses	—			—			—			31.3			—			—			31.3
Management fees	—			—			—			(16.4		)	16.4			—			—
Other	—			—			—			7.9			0.1			—			8.0
Income (loss) from continuing operations before income taxes	(5.1		)	(145.5		)	(32.9		)	118.5			71.1			—			6.1
Income tax benefit (expense)	(8.6		)	—			—			—			(24.0		)	24.0			(8.6		)
Equity in earnings of subsidiaries	1.7			—			—			—			—			(1.7		)	—
Income (loss) from continuing operations	(12.0		)	(145.5		)	(32.9		)	118.5			47.1			22.3			(2.5		)
Loss from discontinued operations, net of taxes	—			—			—			(4.1		)	(1.8		)	—			(5.9		)
Net income (loss)	(12.0		)	(145.5		)	(32.9		)	114.4			45.3			22.3			(8.4		)
Net income attributable to non-controlling interests	—			—			—			—			(3.6		)	—			(3.6		)
Net income (loss) attributable to Vanguard Health Systems, Inc. stockholders	$	(12.0	)	$	(145.5	)	$	(32.9	)	$	114.4		$	41.7		$	22.3		$	(12.0	)

VANGUARD HEALTH SYSTEMS, INC.

Condensed Consolidating Statements of Operations

For the year ended June 30, 2012

	Parent			Issuers of Senior Notes and Term Debt			Issuers of Senior Discount Notes			Guarantor Subsidiaries			Combined Non- Guarantors			Eliminations			Total Consolidated
	(In millions)
Patient service revenues, net	$	—		$	—		$	—		$	4,408.3		$	812.8		$	(29.5	)	$	5,191.6
Premium revenues	—			—			—			87.2			684.2			(14.0		)	757.4
Total revenues	—			—			—			4,495.5			1,497.0			(43.5		)	5,949.0
Salaries and benefits	9.2			—			—			2,220.0			517.7			—			2,746.9
Health plan claims expense	—			—			—			29.5			578.9			(29.5		)	578.9
Supplies	—			—			—			815.0			96.6			—			911.6
Purchased services	—			—			—			452.3			95.0			—			547.3
Rents and leases	—			—			—			55.9			19.1			—			75.0
Other operating expenses	0.4			—			—			451.1			113.5			(14.0		)	551.0
Medicare and Medicaid EHR incentives	—			—			—			(28.0		)	(0.2		)	—			(28.2		)
Depreciation and amortization	—			—			—			221.5			36.8			—			258.3
Interest, net	—			180.9			4.5			(19.1		)	16.5			—			182.8
Impairment and restructuring charges	—			—			—			(0.1		)	—			—			(0.1		)
Debt extinguishment costs	—			—			38.9			—			—			—			38.9
Management fees	—			—			—			(29.9		)	29.9			—			—
Other	—			—			—			2.2			5.8			—			8.0
Income (loss) from continuing operations before income taxes	(9.6		)	(180.9		)	(43.4		)	325.1			(12.6		)	—			78.6
Income tax benefit (expense)	(22.2		)	—			—			—			(15.9		)	15.9			(22.2		)
Equity in earnings of subsidiaries	89.1			—			—			—			—			(89.1		)	—
Income (loss) from continuing operations	57.3			(180.9		)	(43.4		)	325.1			(28.5		)	(73.2		)	56.4
Loss from discontinued operations, net of taxes	—			—			—			(0.5		)	—			—			(0.5		)
Net income (loss)	57.3			(180.9		)	(43.4		)	324.6			(28.5		)	(73.2		)	55.9
Net loss attributable to non-controlling interests	—			—			—			—			1.4			—			1.4
Net income (loss) attributable to Vanguard Health Systems, Inc. stockholders	$	57.3		$	(180.9	)	$	(43.4	)	$	324.6		$	(27.1	)	$	(73.2	)	$	57.3

VANGUARD HEALTH SYSTEMS, INC.

Condensed Consolidating Statements of Operations

For the year ended June 30, 2013

	Parent			Issuers of Senior Notes and Term Debt			Issuers of Senior Discount Notes			Guarantor Subsidiaries			Combined Non- Guarantors			Eliminations			Total Consolidated
	(In millions)
Patient service revenues, net	$	—		$	—		$	—		$	4,389.2		$	900.6		$	(27.5	)	$	5,262.3
Premium revenues	—			—			—			78.9			673.7			(15.5		)	737.1
Total revenues	—			—			—			4,468.1			1,574.3			(43.0		)	5,999.4
Salaries and benefits	6.4			—			—			2,165.2			569.0			—			2,740.6
Health plan claims expense	—			—			—			34.3			570.6			(27.5		)	577.4
Supplies	—			—			—			811.3			105.7			—			917.0
Purchased services	—			—			—			481.1			130.7			—			611.8
Rents and leases	—			—			—			56.4			19.8			—			76.2
Other operating expenses	0.4			—			—			480.0			100.4			(15.5		)	565.3
Medicare and Medicaid EHR incentives	—			—			—			(32.5		)	(5.5		)	—			(38.0		)
Depreciation and amortization	—			—			—			214.7			42.4			—			257.1
Interest, net	—			206.2			0.8			(39.3		)	29.3			—			197.0
Impairment and restructuring charges	—			—			—			4.2			1.0			—			5.2
Debt extinguishment costs	—			1.3			0.8			—			—			—			2.1
Management fees	—			—			—			(13.4		)	13.4			—			—
Other	—			—			—			(22.0		)	(0.1		)	—			(22.1		)
Income (loss) from continuing operations before income taxes	(6.8		)	(207.5		)	(1.6		)	328.1			(2.4		)	—			109.8
Income tax benefit (expense)	(40.8		)	—			—			—			(20.0		)	20.0			(40.8		)
Equity in earnings of subsidiaries	109.5			—			—			—			—			(109.5		)	—
Income (loss) from continuing operations	61.9			(207.5		)	(1.6		)	328.1			(22.4		)	(89.5		)	69.0
Income from discontinued operations, net of taxes	—			—			—			0.1			—			—			0.1
Net income (loss)	61.9			(207.5		)	(1.6		)	328.2			(22.4		)	(89.5		)	69.1
Net income attributable to non-controlling interests	—			—			—			—			(7.2		)	—			(7.2		)
Net income (loss) attributable to Vanguard Health Systems, Inc. stockholders	$	61.9		$	(207.5	)	$	(1.6	)	$	328.2		$	(29.6	)	$	(89.5	)	$	61.9

Schedule of Condensed Comprehensive Income Statements

VANGUARD HEALTH SYSTEMS, INC.

Condensed Consolidating Statements of Comprehensive Income (Loss)

For the year ended June 30, 2011

	Parent			Issuers of Senior Notes and Term Debt			Issuers of Senior Discount Notes			Guarantor Subsidiaries			Combined Non- Guarantors			Eliminations		Total Consolidated
	(in millions)
Net income (loss)	$	(12.0	)	$	(145.5	)	$	(32.9	)	$	114.4		$	45.3		$	22.3	$	(8.4	)
Other comprehensive income:
Change in unrealized holding gains on investments in securities	—			—			—			—			4.5			—		4.5
Change in fair value of pension plan	—			—			—			31.8			—			—		31.8
Change in fair value of other post-retirement benefit plans	—			—			—			0.9			—			—		0.9
Other comprehensive income before taxes	—			—			—			32.7			4.5			—		37.2
Change in income tax expense	—			—			—			(12.4		)	(1.7		)	—		(14.1		)
Other comprehensive income, net of taxes	—			—			—			20.3			2.8			—		23.1
Comprehensive income (loss)	(12.0		)	(145.5		)	(32.9		)	134.7			48.1			22.3		14.7
Net income attributable to non-controlling interests	—			—			—			—			(3.6		)	—		(3.6		)
Comprehensive income (loss) attributable to Vanguard Health Systems, Inc. stockholders	$	(12.0	)	$	(145.5	)	$	(32.9	)	$	134.7		$	44.5		$	22.3	$	11.1

VANGUARD HEALTH SYSTEMS, INC.

Condensed Consolidating Statements of Comprehensive Income (Loss)

For the year ended June 30, 2012

	Parent		Issuers of Senior Notes and Term Debt			Issuers of Senior Discount Notes			Guarantor Subsidiaries			Combined Non- Guarantors			Eliminations			Total Consolidated
	(in millions)
Net income (loss)	$	57.3	$	(180.9	)	$	(43.4	)	$	324.6		$	(28.5	)	$	(73.2	)	$	55.9
Other comprehensive income (loss):
Change in unrealized holding gains on investments in securities	—		—			—			—			0.2			—			0.2
Change in unfunded pension liability	—		—			—			(112.4		)	—			—			(112.4		)
Other comprehensive income (loss) before taxes	—		—			—			(112.4		)	0.2			—			(112.2		)
Change in income tax (expense) benefit	—		—			—			43.3			(0.1		)	—			43.2
Other comprehensive income (loss), net of taxes	—		—			—			(69.1		)	0.1			—			(69.0		)
Comprehensive income (loss)	57.3		(180.9		)	(43.4		)	255.5			(28.4		)	(73.2		)	(13.1		)
Net loss attributable to non-controlling interests	—		—			—			—			1.4			—			1.4
Comprehensive income (loss) attributable to Vanguard Health Systems, Inc. stockholders	$	57.3	$	(180.9	)	$	(43.4	)	$	255.5		$	(27.0	)	$	(73.2	)	$	(11.7	)

VANGUARD HEALTH SYSTEMS, INC.

Condensed Consolidating Statements of Comprehensive Income (Loss)

For the year ended June 30, 2013

	Parent		Issuers of Senior Notes and Term Debt			Issuers of Senior Discount Notes			Guarantor Subsidiaries			Combined Non- Guarantors			Eliminations			Total Consolidated
	(in millions)
Net income (loss)	$	61.9	$	(207.5	)	$	(1.6	)	$	328.2		$	(22.4	)	$	(89.5	)	$	69.1
Other comprehensive income:
Change in unrealized holding gains on investments in securities	—		—			—			—			4.7			—			4.7
Change in unfunded pension liability	—		—			—			61.7			—			—			61.7
Change in fair value of other post-retirement benefit plans	—		—			—			(0.9		)	—			—			(0.9		)
Other comprehensive income before taxes	—		—			—			60.8			4.7			—			65.5
Change in income tax expense	—		—			—			(23.4		)	(1.8		)	—			(25.2		)
Other comprehensive income (loss), net of taxes	—		—			—			37.4			2.9			—			40.3
Comprehensive income (loss)	61.9		(207.5		)	(1.6		)	365.6			(19.5		)	(89.5		)	109.4
Net income attributable to non-controlling interests	—		—			—			—			(7.2		)	—			(7.2		)
Comprehensive income (loss) attributable to Vanguard Health Systems, Inc. stockholders	$	61.9	$	(207.5	)	$	(1.6	)	$	365.6		$	(26.7	)	$	(89.5	)	$	102.2

Schedule of Condensed Cash Flow Statements

VANGUARD HEALTH SYSTEMS, INC.

Condensed Consolidating Statements of Cash Flows

For the year ended June 30, 2011

	Parent			Issuers of Senior Notes and Term Debt			Issuers of Senior Discount Notes			Guarantor Subsidiaries			Combined Non- Guarantors			Eliminations			Total Consolidated
	(In millions)
Operating activities:
Net income (loss)	$	(12.0	)	$	(145.5	)	$	(32.9	)	$	114.4		$	45.3		$	22.3		$	(8.4	)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Loss from discontinued operations	—			—			—			4.1			1.8			—			5.9
Depreciation and amortization	—			—			—			181.9			11.9			—			193.8
Amortization of loan costs	—			5.5			0.8			—			—			—			6.3
Accretion of principal on notes	—			2.8			20.3			—			—			—			23.1
Acquisition related expenses	—			—			—			12.5			—			—			12.5
Stock compensation	4.8			—			—			—			—			—			4.8
Deferred income taxes	3.1			—			—			—			—			—			3.1
Gain on disposal of assets	—			—			—			(0.2		)	—			—			(0.2		)
Other	—			—			—			0.1			(0.5		)	—			(0.4		)
Changes in operating assets and liabilities:
Equity in earnings of subsidiaries	(1.7		)	—			—			—			—			1.7			—
Accounts receivable, net	—			—			—			(66.9		)	(15.3		)	—			(82.2		)
Inventories	—			—			—			2.0			(3.3		)	—			(1.3		)
Prepaid expenses and other current assets	—			—			—			(17.1		)	73.6			—			56.5
Accounts payable	—			—			—			33.3			(2.9		)	—			30.4
Accrued expenses and other liabilities	5.8			9.1			11.8			76.4			(44.5		)	(20.0		)	38.6
Net cash provided by (used in) operating activities — continuing operations	—			(128.1		)	—			340.5			66.1			4.0			282.5
Net cash used in operating activities — discontinued operations	—			—			—			(4.1		)	(1.8		)	—			(5.9		)
Net cash provided by (used in) operating activities	—			(128.1		)	—			336.4			64.3			4.0			276.6

VANGUARD HEALTH SYSTEMS, INC.

Condensed Consolidating Statements of Cash Flows

For the year ended June 30, 2011

(Continued)

	Parent			Issuers of Senior Notes and Term Debt			Issuers of Senior Discount Notes			Guarantor Subsidiaries			Combined Non- Guarantors			Eliminations			Total Consolidated
	(In millions)
Investing activities:
Acquisitions and related expenses, net of cash acquired	$	—		$	—		$	—		$	(464.9	)	$	—		$	—		$	(464.9	)
Capital expenditures	—			—			—			(197.4		)	(9.1		)	—			$	(206.5	)
Net proceeds from sales of investments in securities	—			—			—			114.7			14.3			—			129.0
Other investing activities	—			—			—			(2.5		)	—			—			(2.5		)
Net cash provided by (used in) investing activities	—			—			—			(550.1		)	5.2			—			(544.9		)
Financing activities:
Payments of long-term debt and capital lease obligations	—			(8.1		)	—			(2.5		)	—			—			(10.6		)
Proceeds from debt borrowings	—			566.6			444.6			—			—			—			1,011.2
Dividends to equity holders	(447.2		)	—			—			—			—			—			(447.2		)
Payments of debt issuance costs	—			(5.5		)	(20.4		)	—			—			—			(25.9		)
Proceeds from issuance of common stock	450.0			—			—			—			—			—			450.0
Payments of IPO related costs	(26.9		)	—			—			—			—			—			(26.9		)
Other financing activities	0.4			—			—			(0.2		)	(8.1		)	4.6			(3.3		)
Cash provided by (used in) intercompany activity	23.7			(424.9		)	(424.2		)	661.9			172.1			(8.6		)	—
Net cash provided by (used in) financing activities	—			128.1			—			659.2			164.0			(4.0		)	947.3
Net increase in cash and cash equivalents	—			—			—			445.5			233.5			—			679.0
Cash and cash equivalents, beginning of period	—			—			—			198.6			59.0			—			257.6
Cash and cash equivalents, end of period	$	—		$	—		$	—		$	644.1		$	292.5		$	—		$	936.6

VANGUARD HEALTH SYSTEMS, INC.

Condensed Consolidating Statements of Cash Flows

For the year ended June 30, 2012

	Parent			Issuers of Senior Notes and Term Debt			Issuers of Senior Discount Notes			Guarantor Subsidiaries			Combined Non- Guarantors			Eliminations			Total Consolidated
	(In millions)
Operating activities:
Net income (loss)	$	57.3		$	(180.9	)	$	(43.4	)	$	324.6		$	(28.5	)	$	(73.2	)	$	55.9
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Loss from discontinued operations	—			—			—			0.5			—			—			0.5
Depreciation and amortization	—			—			—			221.5			36.8			—			258.3
Amortization of loan costs	—			6.9			—			—			—			—			6.9
Accretion of principal on notes	—			2.8			4.5			—			—			—			7.3
Acquisition related expenses	—			—			—			8.1			5.9			—			14.0
Stock compensation	9.2			—			—			—			—			—			9.2
Deferred income taxes	15.5			—			—			—			—			—			15.5
Loss on disposal of assets	—			—			—			0.6			—			—			0.6
Debt extinguishment costs	—			—			38.9			—			—			—			38.9
Other	—			—			—			(0.1		)	(0.1		)	—			(0.2		)
Changes in operating assets and liabilities:
Equity in earnings of subsidiaries	(89.1		)	—			—			—			—			89.1			—
Accounts receivable, net	—			—			—			(145.4		)	(32.3		)	—			(177.7		)
Inventories	—			—			—			(9.9		)	4.0			—			(5.9		)
Prepaid expenses and other current assets	—			—			—			(49.2		)	(30.2		)	—			(79.4		)
Accounts payable	—			—			—			41.8			4.6			—			46.4
Accrued expenses and other liabilities	7.1			22.8			—			(53.8		)	(52.3		)	—			(76.2		)
Net cash provided by (used in) operating activities — continuing operations	—			(148.4		)	—			338.7			(92.1		)	15.9			114.1
Net cash used in operating activities — discontinued operations	—			—			—			(0.5		)	—			—			(0.5		)
Net cash provided by (used in) operating activities	—			(148.4		)	—			338.2			(92.1		)	15.9			113.6

VANGUARD HEALTH SYSTEMS, INC.

Condensed Consolidating Statements of Cash Flows

For the year ended June 30, 2012

(Continued)

	Parent			Issuers of Senior Notes and Term Debt			Issuers of Senior Discount Notes			Guarantor Subsidiaries			Combined Non- Guarantors			Eliminations			Total Consolidated
	(In millions)
Investing activities:
Acquisitions and related expenses, net of cash acquired	$	—		$	—		$	—		$	(207.0	)	$	(5.9	)	$	—		$	(212.9	)
Capital expenditures	—			—			—			(269.6		)	(23.7		)	—			(293.3		)
Net proceeds from sales of investments in securities	—			—			—			—			11.8			—			11.8
Net deposits to restricted cash and escrow fund	—			—			—			(20.5		)	—			—			(20.5		)
Other investing activities	—			—			—			1.1			0.6			—			1.7
Net cash used in investing activities	—			—			—			(496.0		)	(17.2		)	—			(513.2		)
Financing activities:
Payments of long-term debt and capital lease obligations	—			(88.1		)	(459.7		)	(2.5		)	(2.8		)	—			(553.1		)
Proceeds from debt borrowings	—			452.2			—			—			—			—			452.2
Payments of debt issuance costs	—			(10.5		)	—			—			—			—			(10.5		)
Proceeds from issuance of common stock	67.5			—			—			—			—			—			67.5
Payments of IPO related costs	(6.9		)	—			—			—			—			—			(6.9		)
Payments of tender premiums on note redemption	—			—			(27.6		)	—			—			—			(27.6		)
Cash provided by (used in) intercompany activity	(59.7		)	(205.2		)	487.3			(178.0		)	(33.5		)	(10.9		)	—
Other financing activities	(0.9		)	—			—			—			2.8			(5.0		)	(3.1		)
Net cash provided by (used in) financing activities	—			148.4			—			(180.5		)	(33.5		)	(15.9		)	(81.5		)
Net decrease in cash and cash equivalents	—			—			—			(338.3		)	(142.8		)	—			(481.1		)
Cash and cash equivalents, beginning of period	—			—			—			644.1			292.5			—			936.6
Cash and cash equivalents, end of period	$	—		$	—		$	—		$	305.8		$	149.7		$	—		$	455.5

VANGUARD HEALTH SYSTEMS, INC.

Condensed Consolidating Statements of Cash Flows

For the year ended June 30, 2013

	Parent			Issuers of Senior Notes and Term Debt			Issuers of Senior Discount Notes			Guarantor Subsidiaries			Combined Non- Guarantors			Eliminations			Total Consolidated
	(In millions)
Operating activities:
Net income (loss)	$	61.9		$	(207.5	)	$	(1.6	)	$	328.2		$	(22.4	)	$	(89.5	)	$	69.1
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Income from discontinued operations	—			—			—			(0.1		)	—			—			(0.1		)
Depreciation and amortization	—			—			—			214.7			42.4			—			257.1
Amortization of loan costs	—			9.2			—			—			—			—			9.2
Accretion of principal on notes	—			3.3			0.7			—			—			—			4.0
Acquisition related expenses	—			—			—			8.1			—			—			8.1
Stock compensation	6.4			—			—			—			—			—			6.4
Deferred income taxes	22.5			—			—			—			—			—			22.5
Gain on disposal of assets	—			—			—			(13.3		)	—			—			(13.3		)
Debt extinguishment costs	—			1.3			0.8			—			—			—			2.1
Other	—			—			—			(0.1		)	0.5			—			0.4
Changes in operating assets and liabilities:
Equity in earnings of subsidiaries	(109.5		)	—			—			—			—			109.5			—
Accounts receivable, net	—			—			—			67.8			(1.9		)	—			65.9
Inventories	—			—			—			(4.7		)	(0.1		)	—			(4.8		)
Prepaid expenses and other current assets	—			—			—			87.3			(26.9		)	—			60.4
Accounts payable	—			—			—			13.8			(3.2		)	—			10.6
Accrued expenses and other liabilities	18.7			0.3			—			(137.4		)	(78.5		)	—			(196.9		)
Net cash provided by (used in) operating activities — continuing operations	—			(193.4		)	(0.1		)	564.3			(90.1		)	20.0			300.7
Net cash provided by operating activities — discontinued operations	—			—			—			0.1			—			—			0.1
Net cash provided by (used in) operating activities	—			(193.4		)	(0.1		)	564.4			(90.1		)	20.0			300.8

VANGUARD HEALTH SYSTEMS, INC.

Condensed Consolidating Statements of Cash Flows

For the year ended June 30, 2013

(Continued)

	Parent			Issuers of Senior Notes and Term Debt			Issuers of Senior Discount Notes			Guarantor Subsidiaries			Combined Non- Guarantors			Eliminations			Total Consolidated
	(In millions)
Investing activities:
Acquisitions and related expenses, net of cash acquired	$	—		$	—		$	—		$	(15.1	)	$	(0.3	)	$	—		$	(15.4	)
Capital expenditures	—			—			—			(395.2		)	(25.3		)	—			(420.5		)
Net proceeds from sales of investments in securities	—			—			—			—			(2.9		)	—			(2.9		)
Net deposits to restricted cash and escrow fund	—			—			—			17.0			—			—			17.0
Other investing activities	—			—			—			15.7			—			—			15.7
Net cash used in investing activities	—			—			—			(377.6		)	(28.5		)	—			(406.1		)
Financing activities:
Payments of long-term debt and capital lease obligations	—			(6.0		)	(10.6		)	(2.1		)	(3.3		)	—			(22.0		)
Proceeds from debt borrowings	—			300.0			—			—			—			—			300.0
Payments of debt issuance costs	—			(2.8		)	—			—			—			—			(2.8		)
Payments of tender premiums on note redemption	—			—			(0.5		)	—			—			—			(0.5		)
Other financing activities	(0.4		)	—			—			—			(0.5		)	—			(0.9		)
Cash provided by (used in) intercompany activity	0.4			(97.8		)	11.2			21.8			84.4			(20.0		)	—
Net cash provided by (used in) financing activities	—			193.4			0.1			19.7			80.6			(20.0		)	273.8
Net increase (decrease) in cash and cash equivalents	—			—			—			206.5			(38.0		)	—			168.5
Cash and cash equivalents, beginning of period	—			—			—			305.8			149.7			—			455.5
Cash and cash equivalents, end of period	$	—		$	—		$	—		$	512.3		$	111.7		$	—		$	624.0